newsfilter
← Latest News
GlobeNewswire·

Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates

BOSTON and SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (NASDAQ:RAPP) ("Rapport" or the "Company"), a clinical-stage biotechnology company dedicated to the discovery and development of small